California’s Prescription Drug Monitoring Program CURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, Schedule III, Schedule IV and Schedule V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement.

CURES is California's prescription drug monitoring program.

On July 1, 2020, the Department promulgated regulations regarding the access and use of CURES, as required by AB-1751 (Statutes of 2018, Chapter 478). This package included, among other things, the following information: The process for approving, denying, and disapproving individuals or entities seeking access to information in CURES.

If a current CURES user is locked out of the system, how can he/she regain access? CURES users are provided easy and prompt online assistance for password resets. Links to these services are on the CURES login page. Additionally, users may contact the CURES Help Desk at (916) 210-3187 or [email protected]. Back to Top. What are Patient Alerts?

The Controlled Substance Utilization Review and Evaluation System (CURES) was certified for statewide use by the Department of Justice (DOJ) on April 2, 2018. Therefore, the mandate to consult CURES prior to prescribing, ordering, administering, or furnishing a

To register with CURES: Visit the Department of Justice (DOJ) CURES webpage. For CURES information and support : Contact [email protected] or (916) 210-3187. For assistance with submitting data: Contact Bamboo Health at (855) 502-0999 (phone) or https://pmpclearinghouse.zendesk.com/hc/en-us .

2024年5月6日 · A prescription drug monitoring program (PDMP) is an electronic database that tracks controlled substance prescriptions. Information from PDMPs can help clinicians identify patients who may be at risk for overdose and provide …

California’s Prescription Drug Monitoring Program CURES 2.0 (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, III and IV controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement.

Physicians are required to consult the CURES database (California’s Prescription Drug Monitoring Database [PDMD]) prior to prescribing Schedule II, III, or IV controlled substances to a patient for the first time and at least once every six months thereafter if that substance remains part of the patient’s treatment.

Beginning August 1, 2024, all California dispensers of controlled substances will be required to report dispensations to the Controlled Substance Utilization Review and Evaluation System (CURES) using the American Society of Automation in Pharmacy (ASAP) version 4.2B format.